medigraphic.com
Anales de Otorrinolaringología Mexicana

2009, Number 3

<< Back Next >>

Otorrinolaringología 2009; 54 (3)

Evaluación de la calidad de vida en pacientes con rinitis alérgica

Muciño HMI, Macías RH, Cruz RAM, Macedo RC, Ochoa PMR, Fuentes OC, González OA

Language: Spanish
References: 29
Page: 102-108
PDF size: 579.28 Kb.


ABSTRACT

Background: The Rhinoconjunctivitis and Rhinitis Quality of Life Questionnaire (RQLQ) is the most standardized method to evaluate the impact of the disease.
Objective: To evaluate the quality of life of allergic rhinitis patients with a specific questionnaire.
Material and method: Descriptive survey. We included 56 patients with diagnosis of persistent allergic rhinitis from January to December 2007. There were 35 women (62.5%).
Results: The mean age was of 28 years (range 12 to 65 years). All of them where diagnosed with persistent, moderate allergic rhinitis in 36 cases, and severe in 20 cases. The most common symptoms were: rhinorrea, congestion or nasal obstruction, sneezing, fatigue, itching, and headache. All the areas had a moderate impact (2.26 to 3.75). The most affected areas were the nasal symptoms, and practical problems (3.75 and 3.73). The lowest scores were observed in sleep disturbance and ocular symptoms (2.26 and 2.46). The correlation between clinical evaluation and the Rhinoconjunctivitis and Rhinitis Quality of Life Questionnaire was r2 = 0.72 and p ‹ 0.05.
Conclusions: The Rhinoconjunctivitis and Rhinitis Quality of Life Questionnaire should be applied to all patients wit the purpose to determine the most affected areas to establish the best medical treatment. It is a cheap instrument and well accepted by the patients.


REFERENCES

  1. Mabry RL. La importancia de la alergia en la práctica de la Otorrinolaringología. En: Derebery MJ. Clínicas otorrinolaringológicas de Norteamérica. Madrid: McGraw-Hill. Cap 12, 2003;pp:739-48.

  2. ARIA recommendations. http://www.whiar.com/pocketguide.html

  3. Zendejas CLH, Martínez PA, Castrejón VMI, Miranda FAJ. Evaluación de la calidad de vida del paciente con rinitis alérgica. Rev Alergia Mex 2003;(3):91-95.

  4. Juniper EF. Measuring health-related quality of life in rhinitis. J Allergy Clin Immunol 1997;99(2):S742-50.

  5. Gungor A. A comparison of skin endpoint titration and skin-prick testing in the diagnosis of allergic rhinitis. Ear Nose Throat J 2004;9:1-9.

  6. Hurst DS, Gordon BR, Fornandley JA, Hunsaker DH. Safety of home-based and office allergy immunotherapy: a multi-center prospective study. Otolaryngol Head Neck Surg 1999;121:553-61.

  7. Krouse JH, Krouse HJ. Efficacy of immunotherapy based on skin end-point titration. Otolaryngol Head Neck Surg 2000;123:183-7.

  8. Krouse JH, Mabry RL. Skin testing for inhalant allergy 2003: current strategies. Otolaryngol Head Neck Surg Suppl 2003;129(4):S33-49.

  9. Juniper EF, Guyatt GH, Griffith LE, Ferrie PJ. Interpretation of rhinoconjunctivitis quality of life questionnaire data. J Allergy Clin Immunol 1996;98(4):845-9.

  10. Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Development and validation of the mini Rhinoconjunctivitis Quality of Life Questionnaire. Clin Exp Allergy 2000;30:132-40.

  11. Juniper E, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 1991;21:77-83.

  12. Moncayo CCV, Rosas VMA, Del Río NBE, Lerma OL, et al. Calidad de vida en niños con rinitis alérgica antes y después de ser tratados con inmunoterapia específica (casos y controles). Rev Alergia Mex 2003;5:170-5.

  13. Bousquet J, Knani J, Dhivert H, et al. Quality of life in asthma. I. Internal consistency and validity of the SF-36 questionnaire. Am J Resp Crit Care Med 1994;149:371-5.

  14. Juniper EF. Can quality of life be quantified? Clin Exp Allergy Rev 2002;2:57-60.

  15. Guyatt GH, Juniper EF, Walter SD, Griffith LE, Goldstein RS. Interpreting treatment effects in randomised trials. Br Med J 1998;316:609-3.

  16. Sarramián BA. Cuestionarios de calidad de vida. Aspectos éticos. Allergol Immunol Clin 2001;16:239-63.

  17. Montaño VBB, Jáuregui RK, Campillo NMR, Mogica MMD, et al. Evaluación de un cuestionario para la medición de síntomas nasales en sujetos con rinitis alérgica. Rev Alergia Mex 2003;50(1)17-21.

  18. Bousquet J, Bullinger M, Fayol C, Marquis P, et al. Assessment of quality of life in patients with perennial rhinitis with the French version of the SF-36 Health Status Questionnaire. J Allergy Clin Immunol 1994;94:182-8.

  19. Chen H, Katz P, Shiboski S, Blanc PD. Evaluating change in health-related quality of life in adult rhinitis: responsiveness of the Rhinosinusitis Disability Index. Health Qual Life Outcomes 2005;3(68):1-11.

  20. Meza R, Espinosa SE, Orozco S, Almendarez C, et al. Rinitis alérgica y calidad de vida en niños del Instituto Nacional de Pediatría. Alergia Asma Inmunol Ped 1998;7(4):119-23.

  21. Dykewicz MS, Fineman S. Executive Summary of Joint Task Force Practice Parameters on Diagnosis and Management of Rhinitis. Ann Allergy Asthma Immunol 1998;81:463-8.

  22. Young T, Finn L, Kim H. Nasal obstruction as a risk factor for Sleep-disordered breathing. The University of Wisconsin sleep and Respiratory Research Group. J Allergy Clin Immunol 1997;99:S757-S762.

  23. Craig TJ, McCann JL, Gurevich F, Davies MJ. The correlation between allergic rhinitis and sleep disturbance. J Allergy Clin Immunol 2004;114:S139-S145.

  24. Shedden A. Impact of nasal congestion on quality of life and work productivity in allergic rhinitis. Treat Respir Med 2005;4:439-46.

  25. Leger D, Annesi-Maesano I, Carat F, et al. Allergic rhinitis and its consequences on quality of sleep. Arch Intern Med 2006;166:1744-8.

  26. Kremer B, den Hartog HM, Jolles J. Relationship between allergic rhinitis, disturbed cognitive functions and psychological well being. Clin Exp Allergy 2002;32:1310-5.

  27. Kakumanu S, Glass C, Craig T. Poor sleep and daytime somnolence in allergic rhinitis: significance of nasal congestion. Am J Resp Med 2002;1:195-200.

  28. Blaiss M, Reigel T, Philpot E. A study to determine the impact of rhinitis on sufferers’ sleep and daily routine. J Allergy Clin Immunol 2005;115(2):S197.

  29. Ariano R, Amoroso S, Astarita C, et al. Quality of life in allergic rhinitis and impact of high-dose sublingual immunotherapy: a real-life study. Clin Exp Allergy 2006;6(3):71-73.




2020     |     www.medigraphic.com